2,6-Diazaspiro[3.4]octan-7-one hydrochloride, 95.0%, 250mg

3-Bromobenzylsulfonamide, 98.0%, 5g

4-Amino-2-fluorobenzotrifluoride, 95.0%, 10g

Ethyl 8-ethoxyoctanoate, 98%, 1g

(3-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid, 95.0%, 250mg

2-((2S)PYRROLIDIN-2-YL)-1,4-DIMETHOXYBENZENE, 95.0%, 250mg

1-(4-methoxybenzoyl)piperazine trifluoroacetate, 95.0%, 10g

3-Chloro-4-methylbenzaldehyde, 95.0%, 25g

tert-Butyl 4-bromo-3-methyl-1H-pyrazole-1-carboxylate, 95.0%, 2g

Microliter syringe GASTIGHT® series 1700 Point type 3, 10 µl, 1701 RNR, 1 piece

Pyrazolo[1,5-a]pyridine-3-carbonitrile, 96%, 500mg

3-Methylbenzofuran-2-carboxylic acid ethyl ester, 97.0%, 100g

2-Bromo-5-nitropyridine, 98.0%, 25g